NEW YORK (TheStreet) --Nasdaq OMX Group (NDAQ) shares should outperform NYSE Group (NYX) shares despite a "challenging environment" for both companies, Citigroup analysts wrote in a research note published Thursday.
NYSE Group faces "more risk of negative earnings revisions," according to the report, given struggles with weaker revenues in its technology division and the prospect of ongoing "tepid" volumes on the Liffe futures exchange, since it is focused on short-dated fixed-income securities.
On the other hand, Nasdaq shares "have arguably suffered" from negative publicity over poor handling of the Facebook (FB) IPO, what Citigroup analysts don't believe will have a "meaningful impact" to earnings growth at the exchange operator.
Citigroup's official recommendation on Nasdaq is "neutral," according to the report, which does not list a recommendation for NYSE. However, Citigroup proposed the overweight to Nasdaq and the underweight to NYSE as part of a "pair trade"--meant to outperform the broader market whether it rises or falls.
As part of the same report, Citigroup recommends CME Group (CME) over shares of the Australian Securities Exchange (ASX) as part of a global pair trade. The report argues the ASX "has more recently started to see an acceleration of downward pressure in its derivative and cash equities businesses." It adds that "the Australian economy has recently shown signs of decelerating on the back of slower growth in China." -- Written by Dan Freed in New York. Follow this writer on Twitter.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV